journal
Journals Pharmacoepidemiology and Drug ...

Pharmacoepidemiology and Drug Safety

https://read.qxmd.com/read/38014926/adherence-to-riluzole-therapy-in-patients-with-amyotrophic-lateral-sclerosis-in-three-italian-regions-the-caesar-study
#1
JOURNAL ARTICLE
Sabrina Giometto, Marco Finocchietti, Olga Paoletti, Niccolò Lombardi, Maria Grazia Celani, Francesco Sciancalepore, Ersilia Lucenteforte, Ursula Kirchmayer
PURPOSE: Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease. Riluzole may increase survival and delay the need for mechanical ventilation. The CAESAR project ('Comparative evaluation of the efficacy and safety of drugs used in rare neuromuscular and neurodegenerative diseases', FV AIFA project 2012-2013-2014) involves evaluating prescribing patterns, and analysing effectiveness and comparative safety of drugs, in patients with neurodegenerative diseases. The aim of this study is to evaluate adherence to riluzole in patients with ALS during the first year of use, identifying adherence clusters...
November 28, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38013249/response-to-the-comment-on-exploring-the-impact-of-design-criteria-for-reference-sets-on-performance-evaluation-of-signal-detection-algorithms-the-case-of-drug-drug-interactions
#2
LETTER
Elpida Kontsioti, Simon Maskell, Munir Pirmohamed
No abstract text is available yet for this article.
November 27, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38011912/risk-of-ischemic-stroke-associated-with-direct-oral-anticoagulants-discontinuation-on-patients-with-non-valvular-atrial-fibrillation
#3
JOURNAL ARTICLE
T Álvaro Thomsen, J Mesa Guadalupe, C Huerta, A de Burgos, L Cea Soriano
INTRODUCTION: Although direct oral anticoagulants' (DOACs) prescriptions have experienced immense growth in the last decade, the proportion of discontinuers is still common yielding an increased risk of ischemic stroke (IS) onset. AIMS: We aimed to estimate the association between DOACs discontinuation and risk of IS among patients with non-valvular atrial fibrillation (NVAF). METHODS: We used data from a cohort of new DOACs users, followed patients from the first DOAC prescription date up to IS (index date) and conducted a nested case-control analysis using conditional logistic regression...
November 27, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/38009550/computational-phenotyping-within-electronic-healthcare-data-to-identify-transgender-people-in-the-united-states-a-narrative-review
#4
REVIEW
Theo G Beltran, Elle Lett, Tonia Poteat, Juan M Hincapie-Castillo
PURPOSE: With the expansion of research utilizing electronic healthcare data to identify transgender (TG) population health trends, the validity of computational phenotype (CP) algorithms to identify TG patients is not well understood. We aim to identify the current state of the literature that has utilized CPs to identify TG people within electronic healthcare data and their validity, potential gaps, and a synthesis of future recommendations based on past studies. METHODS: Authors searched the National Library of Medicine's PubMed, Scopus, and the American Psychological Association PsycInfo's databases to identify studies published in the United States that applied CPs to identify TG people within electronic healthcare data...
November 27, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37994284/a-descriptive-analysis-of-postmarketing-requirement-studies-and-clinical-trials
#5
JOURNAL ARTICLE
Lauren Choi, Beverly Etchey, Monisha Billings, Cathryn Lee, Kathleen M Weil, Debra Boxwell, Helen Edelberg
PURPOSE: Under the Food and Drug Administration Amendments Act of 2007 (FDAAA), the FDA has the authority to require applicants to conduct postmarketing studies or clinical trials. These postmarketing requirements (PMRs) provide additional data on the safety of the drug product. The purpose of the study was to conduct a descriptive analysis of FDAAA PMRs and the resulting regulatory actions. METHODS: This study evaluated FDAAA PMRs established between 2013 and 2019...
November 23, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37985422/is-it-possible-to-identify-risk-factors-for-adverse-drug-reactions-using-a-pharmacovigilance-database-based-on-spontaneous-reporting
#6
LETTER
Yoshihiro Noguchi, Tomoaki Yoshimura
No abstract text is available yet for this article.
November 20, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37985010/successful-implementation-of-a-stakeholder-engagement-program-for-pharmacoepidemiologic-research
#7
JOURNAL ARTICLE
Sara J Cromer, Barbara Steiner, Cassie York, Julianna Mastrorilli, Gillian A Lake, Sherry Leibowitz, Leigh Simmons, Jeanne Steppel-Reznik, Greg Low, Michael A Fischer, Elisabetta Patorno, Deborah J Wexler
PURPOSE: Rigorously conducted pharmacoepidemiologic research requires methodologically complex study designs and analysis yet evaluates problems of high importance to patients and clinicians. Despite this, participation in and mechanisms for stakeholder engagement in pharmacoepidemiologic research are not well-described. Here, we describe our approach and lessons learned from engaging stakeholders, of varying familiarity with research methods, in a rigorous multi-year pharmacoepidemiologic research program evaluating the comparative effectiveness of diabetes medications...
November 20, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37984998/optimizing-large-real-world-data-analysis-with-parquet-files-in-r-a-step-by-step-tutorial
#8
JOURNAL ARTICLE
Abdullah I Abdelaziz, Kent A Hanson, Charles E Gaber, Todd A Lee
PURPOSE: The use of open-source programming languages can facilitate open science practices in real-world evidence (RWE) studies. Real-world studies often rely on using big data, which makes using such languages complicated. We demonstrate an efficient approach that enables RWE researchers to use R to undertake RWE analysis tasks from cohort building to reporting. METHODS: Using the Merative Marketscan data (2017-2019), we developed an R function to transform the data into parquet format to be used in R...
November 20, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37974394/drug-induced-orthostatic-hypotension-cluster-analysis-of-co-prescription-patterns-in-older-people-in-uk-primary-care
#9
JOURNAL ARTICLE
Cini Bhanu, Irene Petersen, Mine Orlu, Daniel Davis, Reecha Sofat, Juan Carlos Bazo-Alvarez, Kate Walters
PURPOSE: Over 250 medications are reported to cause orthostatic hypotension, associated with serious adverse outcomes in older adults. Studies suggest a harmful cumulative risk of orthostatic hypotension with multiple medication use. However, there is limited evidence on the potential for harm in practice, particularly which drugs is co-prescribed and may increase risk of orthostatic hypotension. METHODS: Retrospective cohort study and cluster analysis using general practice data from IQVIA Medical Research Data (IMRD) in patients aged ≥50 contributing data between 1 January 2018 and 31 December 2018...
November 16, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37969030/an-observational-post-authorization-safety-study-pass-of-naloxegol-drug-utilization-in-four-european-countries
#10
JOURNAL ARTICLE
Gunnvald Kvarstein, Anna Ms Kindlundh-Högberg, Mounir Ould Setti, Rafik Namane, Ruvimbo Muzwidzwa, Hartmut Richter, Katja M Hakkarainen
PURPOSE: Naloxegol has been shown to be an efficient alternative to treat opioid-induced constipation (OIC). This study aimed at describing the characteristics of naloxegol users and assessing patterns of naloxegol use and associated factors. METHODS: This drug utilization cohort study used observational registry data on patients newly prescribed naloxegol in four European countries. Patient characteristics and patterns of naloxegol use and associated factors were described...
November 15, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37946587/the-risk-of-miscarriage-after-covid-19-vaccination-before-and-during-pregnancy
#11
JOURNAL ARTICLE
Maud de Feijter, Marleen M H J van Gelder, Lieke C M Vissers, Agnes C Kant, Petra J Woestenberg
PURPOSE: Pregnant women are at higher risk of severe illness and adverse pregnancy outcomes due to a SARS-CoV-2 infection, which can be prevented by vaccination. Observational studies are needed to ascertain the safety of COVID-19 vaccination during pregnancy. We aimed to determine whether COVID-19 vaccination before and during pregnancy is associated with the risk of miscarriage. METHODS: In this cohort study, we included 4640 pregnant women (mean age: 32.8 ± 3...
November 9, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37946583/comment-on-exploring-the-impact-of-design-criteria-for-reference-sets-on-performance-evaluation-of-signal-detection-algorithms-the-case-of-drug-drug-interactions
#12
LETTER
Yoshihiro Noguchi, Tomoaki Yoshimura
No abstract text is available yet for this article.
November 9, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37946571/beta-blocker-use-and-survival-after-pancreatic-cancer-surgery-a-nationwide-population-based-cohort-study
#13
JOURNAL ARTICLE
Jakob Kirkegård, Deirdre Cronin-Fenton, Andrea Lund, Frank Viborg Mortensen
PURPOSE: We examined the association between use of beta-blockers and survival in pancreatic cancer patients after curative-intent surgery. METHODS: Using Danish healthcare registries, we conducted a population-based cohort study of all patients undergoing curative-intent surgery for pancreatic cancer in Denmark 1997-2021. We defined beta-blocker use according to exposure before surgery as current (≤90 days), recent (91-365 days), or former (366-730 days) use, requiring at least one filled prescription...
November 9, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37937883/adherence-and-persistence-of-hiv-pre-exposure-prophylaxis-use-in-the-united-states
#14
JOURNAL ARTICLE
Carter D McCormick, Patrick S Sullivan, Dima M Qato, Stephanie Y Crawford, Glen T Schumock, Todd A Lee
PURPOSE: To describe medication adherence and persistence of HIV PrEP overall and compare between sex and age groups of commercially insured individuals in the United States. METHODS: We conducted a national retrospective cohort study of the Merative MarketScan Claims Database from 2011 - 2019 to describe adherence and persistence of PrEP overall and compared between sex and age groups. High adherence was defined as >80% of proportion of days covered and persistence was measured in days from initiation to the first day of a 60-day treatment gap...
November 8, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37909414/oral-phosphodiesterase-type-5-inhibitors-and-priapism-a-vigibase-analysis
#15
JOURNAL ARTICLE
Behzad Abbasi, Nathan M Shaw, Jason L Lui, Nizar Hakam, Behnam Nabavizadeh, Benjamin N Breyer
PURPOSE: To explore the differences of priapism events among a diverse cohort taking erectogenic medicines (i.e., phosphodiesterase type 5 inhibitors [PDE5i] and intracavernousal drugs). METHODS: We queried the World Health Organization global database of individual case safety reports (VigiBase) for records of the adverse drug reactions (ADR) with sildenafil, tadalafil, avanafil, vardenafil, papaverine, and alprostadil. Disproportionality analyses (case/non-case approach) were performed to assess the reporting odds ratio (ROR) of priapism reporting in PDE5i consumers compared to intracavernousal drug recipients...
November 1, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37909327/trend-adjustment-of-the-sequence-difference-when-performing-sequence-symmetry-analyses
#16
LETTER
Martin Torp Rahbek, Jesper Hallas, Lars Christian Lund
No abstract text is available yet for this article.
November 1, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37885413/application-of-the-waiting-time-distribution-in-a-nationwide-screening-of-real-world-dermatology-drug-utilization-for-aberrant-use-patterns
#17
JOURNAL ARTICLE
Thomas Delvin, Anette Bygum, Lars Christian Lund, Jacob Harbo Andersen, Jesper Hallas
BACKGROUND: Inappropriate use of medicines may have critical consequences from individual, public health, and economic perspectives. Discovering wrongful medicine use may require intentional surveillance or screening. OBJECTIVES: The objectives of this study were to: (i) apply and evaluate the waiting time distribution (WTD) method as a screening tool for identifying aberrant drug use and (ii) evaluate the nationwide use of Dermatology drugs in Denmark for signals of aberrant drug use...
October 27, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37881134/validation-of-an-algorithm-for-identifying-incident-cancer-cases-based-on-long-term-illness-and-diagnosis-related-group-program-data-from-the-french-national-health-insurance-information-system-snds
#18
JOURNAL ARTICLE
Hélène Goulard, Julie Homère, Sylvain Maurisset, Gaëlle Coureau, Gautier Defossez, Tania d'Almeida, Bénédicte Lapôtre-Ledoux, Anne-Valérie Guizard, Véronique Bouvier, Simona Bara, Sandrine Plouvier, Alain Monnereau
PURPOSE: Three generic claims-based algorithms based on the Illness Classification of Diseases (10th revision- ICD-10) codes, French Long-Term Illness (LTI) data, and the Diagnosis Related Group program (DRG) were developed to identify retirees with cancer using data from the French national health insurance information system (Système national des données de santé or SNDS) which covers the entire French population. The present study aimed to calculate the algorithms' performances and to describe false positives and negatives in detail...
October 26, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37876360/incidenceprevalence-an-r-package-to-calculate-population-level-incidence-rates-and-prevalence-using-the-omop-common-data-model
#19
JOURNAL ARTICLE
Berta Raventós, Martí Català, Mike Du, Yuchen Guo, Adam Black, Ger Inberg, Xintong Li, Kim López-Güell, Danielle Newby, Maria de Ridder, Cesar Barboza, Talita Duarte-Salles, Katia Verhamme, Peter Rijnbeek, Daniel Prieto Alhambra, Edward Burn
PURPOSE: Real-world data (RWD) offers a valuable resource for generating population-level disease epidemiology metrics. We aimed to develop a well-tested and user-friendly R package to compute incidence rates and prevalence in data mapped to the observational medical outcomes partnership (OMOP) common data model (CDM). MATERIALS AND METHODS: We created IncidencePrevalence, an R package to support the analysis of population-level incidence rates and point- and period-prevalence in OMOP-formatted data...
October 25, 2023: Pharmacoepidemiology and Drug Safety
https://read.qxmd.com/read/37876341/stratified-analysis-in-comparative-effectiveness-studies-that-emulate-randomized-trials
#20
JOURNAL ARTICLE
Phyo T Htoo, Robert J Glynn, Shirley Wang, Julie M Paik, Sebastian Schneeweiss, Alexander M Walker, Elisabetta Patorno
PURPOSE: For observational cohort studies that employ matching by propensity scores (PS), preliminary stratification by consequential predictors of outcome better emulates stratified randomization and potentially reduces variance and bias through relaxed dependence on modeling assumptions. We assessed the impact of pre-stratification in two real-life examples. For both, prior evidence from placebo-controlled randomized clinical trials (RCTs) suggested small or no risk reduction, but observational analysis suggested protection, presumably the result of confounding bias...
October 25, 2023: Pharmacoepidemiology and Drug Safety
journal
journal
31040
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.